» Articles » PMID: 19073150

RhoA Downstream of G(q) and G(12/13) Pathways Regulates Protease-activated Receptor-mediated Dense Granule Release in Platelets

Overview
Date 2008 Dec 17
PMID 19073150
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet secretion is an important physiological event in hemostasis. The protease-activated receptors, PAR 1 and PAR 4, and the thromboxane receptor activate the G(12/13) pathways, in addition to the G(q) pathways. Here, we investigated the contribution of G(12/13) pathways to platelet dense granule release. 2MeSADP, which does not activate G(12/13) pathways, does not cause dense granule release in aspirin-treated platelets. However, supplementing 2MeSADP with YFLLRNP (60muM), as selective activator of G(12/13) pathways, resulted in dense granule release. Similarly, supplementing PLC activation with G(12/13) stimulation also leads to dense granule release. These results demonstrate that supplemental signaling from G(12/13) is required for G(q)-mediated dense granule release and that ADP fails to cause dense granule release because the platelet P2Y receptors, although activate PLC, do not activate G(12/13) pathways. When RhoA, downstream signaling molecule in G(12/13) pathways, is blocked, PAR-mediated dense granule release is inhibited. Furthermore, ADP activated RhoA downstream of G(q) and upstream of PLC. Finally, RhoA regulated PKCdelta T505 phosphorylation, suggesting that RhoA pathways contribute to platelet secretion through PKCdelta activation. We conclude that G(12/13) pathways, through RhoA, regulate dense granule release and fibrinogen receptor activation in platelets.

Citing Articles

Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell.

Morotti A, Barale C, Melchionda E, Russo I Int J Mol Sci. 2022; 23(19).

PMID: 36232746 PMC: 9570056. DOI: 10.3390/ijms231911446.


Neonatal Platelets: Lower G Expression Contributes to Reduced Secretion of Dense Granules.

Schlagenhauf A, Bohler S, Kunze M, Strini T, Haidl H, Erlacher M Cells. 2022; 11(16).

PMID: 36010639 PMC: 9406762. DOI: 10.3390/cells11162563.


Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches.

Theofilis P, Sagris M, Oikonomou E, Antonopoulos A, Tsioufis K, Tousoulis D Int J Mol Sci. 2022; 23(6).

PMID: 35328719 PMC: 8955963. DOI: 10.3390/ijms23063301.


PAR4-Mediated PI3K/Akt and RhoA/ROCK Signaling Pathways Are Essential for Thrombin-Induced Morphological Changes in MEG-01 Cells.

Heo Y, Jeon H, Namkung W Int J Mol Sci. 2022; 23(2).

PMID: 35054966 PMC: 8775998. DOI: 10.3390/ijms23020776.


The role of protease-activated receptor 1 signaling in CD8 T cell effector functions.

Chen H, Smith M, Herz J, Li T, Hasley R, Le Saout C iScience. 2021; 24(11):103387.

PMID: 34841225 PMC: 8605340. DOI: 10.1016/j.isci.2021.103387.


References
1.
Offermanns S, Toombs C, Hu Y, Simon M . Defective platelet activation in G alpha(q)-deficient mice. Nature. 1997; 389(6647):183-6. DOI: 10.1038/38284. View

2.
Jin J, Daniel J, Kunapuli S . Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem. 1998; 273(4):2030-4. DOI: 10.1074/jbc.273.4.2030. View

3.
Nieswandt B, Schulte V, Zywietz A, Gratacap M, Offermanns S . Costimulation of Gi- and G12/G13-mediated signaling pathways induces integrin alpha IIbbeta 3 activation in platelets. J Biol Chem. 2002; 277(42):39493-8. DOI: 10.1074/jbc.M207256200. View

4.
Klages B, Brandt U, Simon M, Schultz G, Offermanns S . Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol. 1999; 144(4):745-54. PMC: 2132941. DOI: 10.1083/jcb.144.4.745. View

5.
Rybin V, Sabri A, Short J, Braz J, Molkentin J, Steinberg S . Cross-regulation of novel protein kinase C (PKC) isoform function in cardiomyocytes. Role of PKC epsilon in activation loop phosphorylations and PKC delta in hydrophobic motif phosphorylations. J Biol Chem. 2003; 278(16):14555-64. DOI: 10.1074/jbc.M212644200. View